Metabolic syndrome in parathyroid diseases

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Parathyroid glands are the main regulator of body mineral metabolism through parathormone (PTH) actions on bone and kidney. Experimental evidence suggests that PTH may have non-classical target organs such as adipose tissue, arterial vascular wall, cardiac muscle cells, and adrenal cortex cells, where it may play a role in controlling body energy, blood pressure, and metabolism. Cardiometabolic features have been investigated in the wide spectrum of clinical parathyroid disorders, from hyperparathyroidism to pseudohypoparathyroidism and hypoparathyroidism. Indeed, in parathyroid disorders, besides altered PTH secretion, impaired serum calcium levels and vitamin D status occur. Both calcium and vitamin D have been shown to regulate metabolism and to be associated with cardiovascular diseases. However, despite the complexity of parathyroid disorders, features of metabolic syndrome, such as obesity, insulin resistance, and glucose intolerance, arterial blood hypertension, and dyslipidemia, are frequently diagnosed in primary and secondary hyperparathyroidism as well as in pseudohyperparathyroidism. Here, we reviewed the most consistent data highlighting challenges and providing clinical remarks.

Original languageEnglish
Pages (from-to)67-84
Number of pages18
JournalFrontiers of Hormone Research
Volume49
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Parathyroid Diseases
Parathyroid Hormone
Vitamin D
Pseudohypoparathyroidism
Calcium
Hypoparathyroidism
Secondary Hyperparathyroidism
Parathyroid Glands
Glucose Intolerance
Primary Hyperparathyroidism
Hyperparathyroidism
Adrenal Cortex
Dyslipidemias
Cardiac Myocytes
Minerals
Blood Vessels
Insulin Resistance
Adipose Tissue
Cardiovascular Diseases
Obesity

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Metabolic syndrome in parathyroid diseases. / Corbetta, Sabrina; Mantovani, G.; Spada, A.

In: Frontiers of Hormone Research, Vol. 49, 01.01.2018, p. 67-84.

Research output: Contribution to journalArticle

@article{5772efb825f9475d9926867dd347e9f8,
title = "Metabolic syndrome in parathyroid diseases",
abstract = "Parathyroid glands are the main regulator of body mineral metabolism through parathormone (PTH) actions on bone and kidney. Experimental evidence suggests that PTH may have non-classical target organs such as adipose tissue, arterial vascular wall, cardiac muscle cells, and adrenal cortex cells, where it may play a role in controlling body energy, blood pressure, and metabolism. Cardiometabolic features have been investigated in the wide spectrum of clinical parathyroid disorders, from hyperparathyroidism to pseudohypoparathyroidism and hypoparathyroidism. Indeed, in parathyroid disorders, besides altered PTH secretion, impaired serum calcium levels and vitamin D status occur. Both calcium and vitamin D have been shown to regulate metabolism and to be associated with cardiovascular diseases. However, despite the complexity of parathyroid disorders, features of metabolic syndrome, such as obesity, insulin resistance, and glucose intolerance, arterial blood hypertension, and dyslipidemia, are frequently diagnosed in primary and secondary hyperparathyroidism as well as in pseudohyperparathyroidism. Here, we reviewed the most consistent data highlighting challenges and providing clinical remarks.",
author = "Sabrina Corbetta and G. Mantovani and A. Spada",
year = "2018",
month = "1",
day = "1",
doi = "10.1159/000486003",
language = "English",
volume = "49",
pages = "67--84",
journal = "Frontiers of Hormone Research",
issn = "0301-3073",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Metabolic syndrome in parathyroid diseases

AU - Corbetta, Sabrina

AU - Mantovani, G.

AU - Spada, A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Parathyroid glands are the main regulator of body mineral metabolism through parathormone (PTH) actions on bone and kidney. Experimental evidence suggests that PTH may have non-classical target organs such as adipose tissue, arterial vascular wall, cardiac muscle cells, and adrenal cortex cells, where it may play a role in controlling body energy, blood pressure, and metabolism. Cardiometabolic features have been investigated in the wide spectrum of clinical parathyroid disorders, from hyperparathyroidism to pseudohypoparathyroidism and hypoparathyroidism. Indeed, in parathyroid disorders, besides altered PTH secretion, impaired serum calcium levels and vitamin D status occur. Both calcium and vitamin D have been shown to regulate metabolism and to be associated with cardiovascular diseases. However, despite the complexity of parathyroid disorders, features of metabolic syndrome, such as obesity, insulin resistance, and glucose intolerance, arterial blood hypertension, and dyslipidemia, are frequently diagnosed in primary and secondary hyperparathyroidism as well as in pseudohyperparathyroidism. Here, we reviewed the most consistent data highlighting challenges and providing clinical remarks.

AB - Parathyroid glands are the main regulator of body mineral metabolism through parathormone (PTH) actions on bone and kidney. Experimental evidence suggests that PTH may have non-classical target organs such as adipose tissue, arterial vascular wall, cardiac muscle cells, and adrenal cortex cells, where it may play a role in controlling body energy, blood pressure, and metabolism. Cardiometabolic features have been investigated in the wide spectrum of clinical parathyroid disorders, from hyperparathyroidism to pseudohypoparathyroidism and hypoparathyroidism. Indeed, in parathyroid disorders, besides altered PTH secretion, impaired serum calcium levels and vitamin D status occur. Both calcium and vitamin D have been shown to regulate metabolism and to be associated with cardiovascular diseases. However, despite the complexity of parathyroid disorders, features of metabolic syndrome, such as obesity, insulin resistance, and glucose intolerance, arterial blood hypertension, and dyslipidemia, are frequently diagnosed in primary and secondary hyperparathyroidism as well as in pseudohyperparathyroidism. Here, we reviewed the most consistent data highlighting challenges and providing clinical remarks.

UR - http://www.scopus.com/inward/record.url?scp=85045118710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045118710&partnerID=8YFLogxK

U2 - 10.1159/000486003

DO - 10.1159/000486003

M3 - Article

AN - SCOPUS:85045118710

VL - 49

SP - 67

EP - 84

JO - Frontiers of Hormone Research

JF - Frontiers of Hormone Research

SN - 0301-3073

ER -